Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease-Reference-Cited by-同舟云学术

Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease

Published:2009-08 Issue:35 Volume:284 Page:23502-23516
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Maegawa Gustavo H.B.,Tropak Michael B.,Buttner Justin D.,Rigat Brigitte A.,Fuller Maria,Pandit Deepangi,Tang Liangiie,Kornhaber Gregory J.,Hamuro Yoshitomo,Clarke Joe T.R.,Mahuran Don J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference72 articles.

1. Gaucher disease plus.

2. Gaucher disease: perspectives on a prototype lysosomal disease

3. The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations

4. Parkinsonism among Gaucher disease carriers

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and preclinical insights into high-dose ambroxol therapy for Gaucher disease type 2 and 3: A comprehensive systematic review;Molecular Genetics and Metabolism;2024-09

2. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09

3. Gaucher disease provides a unique window into Parkinson disease pathogenesis;Nature Reviews Neurology;2024-08-06

4. Iminosugar‐Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers;Chemistry & Biodiversity;2024-07-23

5. GBA1-Associated Parkinson’s Disease Is a Distinct Entity;International Journal of Molecular Sciences;2024-06-28